Submitted by Anonymous (not verified) on 30 July 2025 - 15:32
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 37, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 37, Status: Authorised